Hutchmed drug approved in China for advanced gastric cancer
(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer with "a very poor prognosis". Read More
| Price | 173.00p on 14-07-2026 at 17:55:15 |
|---|---|
| Change | 1.50p 0.87% |
| Buy | 174.50p |
| Sell | 170.00p |
| Last Trade: | Buy 2.00 at 173.00p |
| Day's Volume: | 9,642 |
| Last Close: | 173.00p |
| Open: | 170.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 170.00p - 174.50p |
| 52wk Range: | 153.00p - 292.00p |
| Market Capitalisation: | £1.49b |
| VWAP: | 170.12963p |
| Shares in Issue: | 859.75m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2 | 173.00p | Suspected BUY Trade |
16:35:18 - 14-Jul-26 |
| Buy* | 56 | 174.00p | Automatic Execution |
16:29:10 - 14-Jul-26 |
| Buy* | 30 | 171.50p | Automatic Execution |
16:26:02 - 14-Jul-26 |
| Buy* | 34 | 171.50p | Automatic Execution |
16:24:01 - 14-Jul-26 |
| Buy* | 48 | 171.50p | Automatic Execution |
16:23:25 - 14-Jul-26 |
| Sell* | 166 | 170.00p | Automatic Execution |
16:23:22 - 14-Jul-26 |
| Sell* | 230 | 170.00p | Automatic Execution |
16:23:22 - 14-Jul-26 |
| Sell* | 715 | 170.00p | Automatic Execution |
16:23:22 - 14-Jul-26 |
| Buy* | 53 | 174.00p | Automatic Execution |
16:22:18 - 14-Jul-26 |
| Buy* | 36 | 174.00p | Automatic Execution |
16:22:18 - 14-Jul-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Jul 2026 9:30 am | RNS | HUTCHMED Announces NMPA Approval for ORPATHYS |
| 30th Jun 2026 9:30 am | RNS | HUTCHMED to Announce 2026 Half-Year Results |
| 29th Jun 2026 9:30 am | RNS | Announcement on blocklisting six monthly return |
| 25th Jun 2026 7:00 am | RNS-R | HUTCHMED Highlights Phase II Data at ESMO |
| 12th Jun 2026 7:00 am | RNS-R | HUTCHMED Highlights Sovleplenib Phase III Data |
| 5th Jun 2026 9:30 am | RNS | Block Admission Application |
| 22nd May 2026 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at ASCO |
| 21st May 2026 11:00 am | RNS-R | NMPA approval for ELUNATE with TYVYT |
| 12th May 2026 12:45 pm | RNS | Announcement on Results of Annual General Meeting |
| 30th Apr 2026 9:30 am | RNS | Total Voting Rights |